Physician profile
Lindsey Malone
NPI 1134361454
$2,042.36
in general payments reported to CMS, 2019-2025
34 companies · $426 in 2025
The $426 reported for 2025 was more than what 75% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $115 · 2021: $156 · 2022: $465 · 2023: $286 · 2024: $249 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $231.38 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Aptima |
| Abbvie INC. | $162.78 | 2019-2023 | |
| Organon LLC | $146.55 | 2022-2025 | Nexplanon |
| Therapeuticsmd, INC. | $117.43 | 2019-2022 | |
| Pfizer INC. | $116.80 | 2020-2024 | |
| Allergan, INC. | $98.35 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $89.49 | 2022-2025 | |
| Agile Therapeutics, INC. | $82.57 | 2021-2023 | Twirla |
| Exeltis, USA INC. | $81.14 | 2022-2024 | Slynd |
| Gynesonics, INC. | $75.21 | 2022 | |
| Novo Nordisk INC | $73.18 | 2022-2025 | Wegovy |
| Astellas Pharma US INC | $73.18 | 2025 | Veozah |
| Avion Pharmaceuticals | $57.81 | 2019-2023 | Balcoltra |
| Exact Sciences Corporation | $55.82 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Aspira Women'S Health INC | $55.42 | 2021-2024 | Ova1 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $50.63 | 2025 | Prevena, Activ.A.C. |
| Mylan Pharmaceuticals INC. | $43.58 | 2019 | |
| Channel Medsystems, INC. | $42.26 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.24 | 2019-2025 | |
| Amgen INC. | $39.70 | 2019-2023 | Evenity, Prolia |
| Lupin INC. | $39.33 | 2019 | |
| Biogen, INC. | $35.75 | 2024-2025 | Zurzuvae |
| Dysis Medical, INC. | $30.99 | 2020 | |
| Sanofi Pasteur INC. | $26.26 | 2024 | |
| Minerva Surgical, INC | $25.20 | 2019-2022 | |
| Millicent US INC | $24.81 | 2025 | Femlyv |
| Alexion Pharmaceuticals, INC. | $22.01 | 2019 | |
| Coopersurgical, INC. | $17.44 | 2023 | Summit Doppler |
| Scynexis, INC. | $14.90 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.84 | 2019 | |
| Lilly USA, LLC | $14.50 | 2025 | Zepbound |
| Shield Therapeutics INC | $14.28 | 2023 | Accrufer |
| Covidien LP | $13.92 | 2020 | |
| Merck Sharp & Dohme LLC | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.